Lead Sponsor

Sanofi

Collaborators

Age

12 - No limit years

Sex

ALL

Healthy Volunteers

No

•Male or female, 12 years or older at the baseline visit. Note: Adolescent participants (at least 12 years old, but less than 18 years) are eligible only after Dupixent® receives the respective country's regulatory approval for use in this age group;
•Able to understand and complete study-related questionnaires
•Provide signed informed consent or parental/legally acceptable representative consent and/or patient assent where applicable

•Participants who have a contraindication to the drug according to the country-specific prescribing information label
•Any condition that, in the opinion of the investigator, may interfere with patient's ability to participate in the study, such as short life expectancy, substance abuse, severe cognitive impairment, or other co-morbidities that can predictably prevent the participant patient from adequately completing the schedule of visits and assessments
•Patients currently participating in any interventional clinical trial which modifies patient care
•Prior use of Dupixent® within 6 months of the screening visit, or within 6 months of the baseline visit if screening and baseline occur on the same day
•The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.